Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Catalyzing Decisions in Pharma-Biotech Collaborations

Posted on March 4th, 2016 by in Pharma R&D

Despite large strides in technological and scientific progress, the cost to develop and release a new drug has escalated dramatically (1). At the same time, the number of generic drugs has grown in the last decade (2). In the U.S., 70% of Continue reading “Catalyzing Decisions in Pharma-Biotech Collaborations” »